Orah Nutrichem Profile
Key Indicators
- Authorised Capital ₹ 9.00 M
as on 16-11-2024
- Paid Up Capital ₹ 9.00 M
as on 16-11-2024
- Company Age 8 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 6.00 M
as on 16-11-2024
- Revenue 136.16%
(FY 2023)
- Profit 428.32%
(FY 2023)
- Ebitda 205.73%
(FY 2023)
- Net Worth 201.23%
(FY 2023)
- Total Assets 21.96%
(FY 2023)
About Orah Nutrichem
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 9.00 M and a paid-up capital of Rs 9.00 M.
The company currently has active open charges totaling ₹6.00 M.
Vinay Paranjpe, Rohit Dubepatil, Kavita Dubepatil, and One other member serve as directors at the Company.
- CIN/LLPIN
U24306PN2016PTC164375
- Company No.
164375
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 May 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Orah Nutrichem?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vinay Paranjpe  | Director | 07-May-2016 | Current |
| Rohit Dubepatil | Whole-Time Director | 07-May-2016 | Current |
| Kavita Dubepatil | Director | 01-Feb-2020 | Current |
Rajul Malde  | Director | 20-Apr-2020 | Current |
Financial Performance of Orah Nutrichem.
Orah Nutrichem Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 136.16% increase. The company also saw a substantial improvement in profitability, with a 428.32% increase in profit. The company's net worth Soared by an impressive increase of 201.23%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Orah Nutrichem?
In 2023, Orah Nutrichem had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Orah Infra Resources LlpActive 3 years 8 monthsVinay Paranjpe, Rohit Dubepatil and 2 more are mutual person
- Pemgiri Social FoundationActive 8 months 6 days
Rohit Dubepatil and Kavita Dubepatil are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 26 Feb 2024 | ₹6.00 M | Open |
How Many Employees Work at Orah Nutrichem?
Unlock and access historical data on people associated with Orah Nutrichem, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Orah Nutrichem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Orah Nutrichem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
